New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients
Details of a new 6,000 patient study of dabigatran etexilate…
8 May 2014 | By Boehringer Ingelheim
Details of a new 6,000 patient study of dabigatran etexilate were announced at the European Stroke Conference, Nice, France...